ACP Journal Club. Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs
- PMID: 23552833
- DOI: 10.7326/0003-4819-158-6-201303190-02007
ACP Journal Club. Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs
Comment on
-
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121378 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous